Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 1.21 M1.2 M1.4 M2.58 M 6.38 M Research & development ———— — Operating income -145 K-479 K82 K-3.04 M -3.59 M Non-Operating Income, Total -170 K-176 K-231 K-155 K -732 K Interest expense, net of interest capitalized 188 K190 K243 K219 K 840 K Non-Operating Income, excl. Interest Expenses -179 K-183 K-237 K-187 K -786 K Unusual income/expense -179 K-183 K-237 K-187 K -786 K Pretax income -324 K-662 K-155 K-3.23 M -4.37 M Equity in earnings ———— — Taxes 000187 K 187 K Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -324 K-662 K-155 K-3.42 M -4.56 M Discontinued operations ———0 — Net income -324 K-662 K-155 K-3.42 M -4.56 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -324 K-662 K-155 K-3.42 M -4.56 M Basic earnings per share (Basic EPS) -0.04-0.09-0.02-0.41 -0.56 Diluted earnings per share (Diluted EPS) -0.04-0.09-0.02-0.41 -0.56 Average basic shares outstanding 7.74 M7.79 M7.8 M8.08 M — Diluted shares outstanding 7.74 M7.79 M7.8 M8.08 M — EBITDA 201 K-134 K427 K-2.68 M -2.18 M EBIT -145 K-479 K82 K-3.04 M -3.59 M Cost of revenue 4.39 M5.22 M4.98 M6.06 M 20.64 M Other cost of goods sold 1.03 M1.02 M1.17 M1.18 M 4.4 M Depreciation & amortization (cash flow) 346 K345 K345 K369 K 1.41 M